XM does not provide services to residents of the United States of America.

Top of the Street: Roche, Inditex, Lanxess, Fortum

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-Top of the Street: Roche, Inditex, Lanxess, Fortum</title></head><body>

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** Jefferies cuts German chemicals maker Lanxess LXSG.DE to "underperform" from "hold", citing a too-high financial risk related to its debt

** Morgan Stanley downgrades UK-based online car marketplace Auto Trader Group AUTOA.L to "underweight" from "equal-weight", saying the "Deal Builder" service is not driving meaningful growth for another 1-2 years

** Deutsche Bank upgrades Swiss biotech firm Roche ROG.S to "hold" from "sell" on improved outlook for obesity drug success

** RBC cuts Zara owner Inditex ITX.MC to "sector perform" from "outperform", saying it is less leveraged than H&M HMb.ST and Primark to favourable FX in H1 and falling raw material prices, such as cotton

** UBS cuts Finnish utility Fortum FORTUM.HE to "sell" from "neutral", seeing declining power prices putting pressure on the company's earnings that its organic growth cannot balance


** Morgan Stanley initiates French service provider Spie SPIE.PA at "overweight", saying the "new SPIE" is not fully priced in as demand for multi-technical services booms

** Bernstein starts German telecoms provider Deutsche Telekom DTEGn.DE with "outperform", saying its growth outlook and current valuation outweigh concerns about German salary inflation, the likely share placement and its US investments and offer a "compelling buy opportunity"

** Jefferies resumes coverage of logistics real estate specialist Tritax Big Box BBOXT.L with a "buy" rating saying the acquisition of UK Commercial Property UKCM.L broadens its portfolio in terms of building sizes and locations

(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

Reporting by Antonis Pothitos and Jagoda Darlak in Gdansk


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.